Compare DraftKings Inc (DKNG) vs Zoetis Inc (ZTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DraftKings Inc vs Zoetis Inc — how do they compare? DraftKings Inc trades at $19.58 (market cap $9.86B), while Zoetis Inc trades at $74.77 (market cap $30.20B). The key difference: Zoetis Inc is far larger — about 3.1× DraftKings Inc's market cap, and Zoetis Inc pays a 2.9% dividend while DraftKings Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold DraftKings Inc for 55 Days and Zoetis Inc for 70 Days on average.
| DKNG | ZTS | |
|---|---|---|
Market Cap | $9.86B | $30.20B |
Volume | 16,584,596 | 6,175,327 |
Sector | Consumer Cyclical | Health |
52-Week High | $36.24 | $147.53 |
52-Week Low | $18.59 | $69.09 |
Typical Hold Time | 55 Days | 70 Days |
Enterprise Value | $10.80B | $37.76B |
Dividend Yield | — | 2.9% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DraftKings (DKNG) trades at $19.87, down 3.76% but showing signs of fundamental improvement with revenue growth from $2.2B in 2022 to $6.05B in 2025 and achieving its first profitable year. The stock faces technical bearish signals with recent price weakness, hitting a new 52-week low near $19 support levels. Recent news highlights the company's DKeX rollout and NHL partnership while facing margin concerns from prediction market investments.
Despite current bearish technicals, DKNG's path to profitability and strong analyst consensus ($33.13 price target, 75% buy ratings) suggest long-term potential. Key risks include high valuation multiples (P/E 246.33), competitive pressures, and regulatory uncertainty in sports betting markets. The company's $1B EBITDA target for 2026 and prediction market expansion provide growth catalysts if execution succeeds.
Zoetis (ZTS) trades at $73.08, up 2.14% today, with a bullish technical signal but mixed earnings history including a recent Q1 2026 miss. The stock shows strong profitability with a 27.69% net income margin and 64.91% ROE, while valuation metrics like a P/E of 11.92 appear reasonable. Recent news highlights competitive pressures in the U.S. pet care market, though international segments remain resilient.
The outlook is cautiously optimistic; ZTS faces near-term headwinds from weak U.S. demand and competition, but its industry-leading margins and dominant market position support long-term growth. Risks include pricing erosion and guidance cuts, yet the consensus price target of $87.33 suggests upside potential for patient investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About DraftKings Inc
DraftKings Inc is a digital sports entertainment and gaming company. The company provides users with daily fantasy sports (DFS), sports betting, and iGaming opportunities and is also involved in the design & development of sports betting and casino gaming platform software for online and retail sportsbook and casino gaming products. It operates in two segments: Business-to-consumer(B2C) and Business-to-Business(B2B), of which the vast majority of its revenue comes from the B2C segment. Geographically, it derives most of its revenue from the United States.
Read more on DKNG →About Zoetis Inc
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →
